Compare GSK Pharma with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA CIPLA GSK PHARMA/
CIPLA
 
P/E (TTM) x 59.1 27.5 215.1% View Chart
P/BV x 19.6 3.9 502.2% View Chart
Dividend Yield % 1.7 0.6 306.0%  

Financials

 GSK PHARMA   CIPLA
EQUITY SHARE DATA
    GSK PHARMA
Mar-21
CIPLA
Mar-21
GSK PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,805879 205.5%   
Low Rs1,155411 281.2%   
Sales per share (Unadj.) Rs188.8237.6 79.5%  
Earnings per share (Unadj.) Rs21.129.8 71.0%  
Cash flow per share (Unadj.) Rs25.843.0 60.0%  
Dividends per share (Unadj.) Rs30.005.00 600.0%  
Avg Dividend yield %2.00.8 261.3%  
Book value per share (Unadj.) Rs88.5226.7 39.0%  
Shares outstanding (eoy) m169.41806.46 21.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x7.82.7 288.9%   
Avg P/E ratio x70.021.6 323.4%  
P/CF ratio (eoy) x57.315.0 382.5%  
Price / Book Value ratio x16.72.8 588.2%  
Dividend payout %141.916.8 845.0%   
Avg Mkt Cap Rs m250,695519,826 48.2%   
No. of employees `000NANA-   
Total wages/salary Rs m6,14732,518 18.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m31,989191,596 16.7%  
Other income Rs m1,1062,698 41.0%   
Total revenues Rs m33,094194,294 17.0%   
Gross profit Rs m5,22742,487 12.3%  
Depreciation Rs m79310,677 7.4%   
Interest Rs m351,607 2.2%   
Profit before tax Rs m5,50532,901 16.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,9248,888 21.6%   
Profit after tax Rs m3,58124,013 14.9%  
Gross profit margin %16.322.2 73.7%  
Effective tax rate %34.927.0 129.3%   
Net profit margin %11.212.5 89.3%  
BALANCE SHEET DATA
Current assets Rs m22,027132,095 16.7%   
Current liabilities Rs m13,32545,916 29.0%   
Net working cap to sales %27.245.0 60.5%  
Current ratio x1.72.9 57.5%  
Inventory Days Days4768 69.2%  
Debtors Days Days2467 3,747.8%  
Net fixed assets Rs m8,076116,277 6.9%   
Share capital Rs m1,6941,613 105.0%   
"Free" reserves Rs m13,297181,232 7.3%   
Net worth Rs m14,991182,844 8.2%   
Long term debt Rs m012,028 0.0%   
Total assets Rs m30,102248,372 12.1%  
Interest coverage x156.921.5 730.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.10.8 137.8%   
Return on assets %12.010.3 116.5%  
Return on equity %23.913.1 181.9%  
Return on capital %37.017.7 208.7%  
Exports to sales %031.3 0.0%   
Imports to sales %0.910.9 7.9%   
Exports (fob) Rs mNA59,951 0.0%   
Imports (cif) Rs m27620,911 1.3%   
Fx inflow Rs m27868,051 0.4%   
Fx outflow Rs m27620,911 1.3%   
Net fx Rs m247,140 0.0%   
CASH FLOW
From Operations Rs m5,77937,552 15.4%  
From Investments Rs m4,186-23,872 -17.5%  
From Financial Activity Rs m-6,961-13,299 52.3%  
Net Cashflow Rs m3,004509 590.0%  

Share Holding

Indian Promoters % 0.0 14.8 -  
Foreign collaborators % 75.0 22.4 335.3%  
Indian inst/Mut Fund % 12.8 38.1 33.5%  
FIIs % 2.0 23.9 8.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 62.8 39.8%  
Shareholders   123,480 201,096 61.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   SUN PHARMA    LUPIN    AUROBINDO PHARMA    DR. REDDYS LAB    CADILA HEALTHCARE    



Today's Market

4 Reasons Why Sensex Plunged 634 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

GSK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of GSK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

CIPLA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of CIPLA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Jan 20, 2022 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA - VAISHALI PHARMA COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS